Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Pain
Interventions
DRUG

Bupivacaine

"Bupivacaine will be administered bilaterally to the parasternal intercostal spaces during surgery according to these doses:~Under 20kgs weight: 0.25% Bupivacaine at 1 milliliter/kilogram (1ml/kg); Above 20kgs weight: 0.5% Bupivacaine at 0.5 ml/kg up to a maximum of 25ml of 0.5% Bupivacaine for patients \> 50 kgs"

DRUG

Placebo

"Saline will be administered bilaterally to the parasternal intercostal spaces during surgery according to these doses:~Under 20kgs weight: 1 milliliter/kilogram (1ml/kg); Above 20kgs weight: 0.5 ml/kg up to a maximum of 25ml for patients \> 50 kgs"

Trial Locations (1)

55404

Children's Hospitals and Clinics of Minnesota, Minneapolis

All Listed Sponsors
lead

Children's Hospitals and Clinics of Minnesota

OTHER

NCT02512861 - Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter